Simonds, S
This exclusion was written into the Medicare Part D prescription drug program when it was created, reflecting the political reality that weight loss medications were viewed as lifestyle drugs rather than treatments for serious medical conditions
The glucagon receptor component also drives metabolic benefits that operate independently of weight loss cardiovascular risk marker improvements including non-HDL cholesterol reduction, triglyceride reduction, high-sensitivity C-reactive protein reduction, and at the highest dose, a 14mmHg reduction in systolic blood pressure
Many users also present with hypertension, sleep apnea or other conditions that strengthen the case for structured care
Patients are taught: How to prepare and inject safely into areas such as the abdomen, thigh, or upper arm How to rotate injection sites to prevent skin irritation Safe disposal of used pens or needles The process is simple and takes only a few seconds, but patient education is essential to ensure confidence and consistency
2024), whereas centrally-acting agents like phentermine/topiramate focused solely on appetite pathways, achieving a weight loss of 79% (Coulter et al
.png)
